Literature DB >> 2471213

Use of a 7.5% NaCl/6% Dextran 70 solution in the resuscitation of injured patients in the emergency room.

J W Holcroft1, M J Vassar, C A Perry, W L Gannaway, G C Kramer.   

Abstract

Animal studies and preliminary field patient trials suggest that hypertonic saline solutions can achieve resuscitation of hypovolemic shock with extremely small volumes. In the study reported here, we evaluated the effects of a hypertonic 7.5% NaCl/6% Dextran 70 (HSD) solution in the resuscitation of patients in the emergency room. Thirty-two patients were randomized into a prospective, randomized, placebo-controlled, double-blinded trial in which 250 ml of either HSD or, as a control, lactated Ringers (LR) was used as the initial fluid for resuscitation of patients with systolic blood pressures of 80 mmHg or less. The test solution was given intravenously, usually through a saphenous vein cut-down, over a period of 2-5 minutes. Conventional isotonic solutions were then given as necessary with an average of 2500 ml of fluid being given over the first 30 minutes of resuscitation. Survival was not improved, and the trial proved to be of most interest with regard to measurement of physiological quantities, which might have been expected to have been substantially abnormal because, in many cases, the measurements were made shortly after the infusion ran in. Very few abnormalities, however, were in fact detected. With the exception of one patient, the highest sodium concentration was 156 mEq/l, the highest chloride concentration was 126 mEq/1, and the highest osmolality was 401 mOsm/kg, and this value was obtained in a patient in the control LR group. Osmolality correlated far better with blood alcohol levels (Spearman's rank correlation coefficient = 0.81) than with any other variable, including sodium and chloride concentrations. The HSD solution was safe to use.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471213

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  8 in total

Review 1.  7.5% saline and 7.5% saline/6% dextran for hypovolemic shock.

Authors:  Eileen M Bulger
Journal:  J Trauma       Date:  2011-05

2.  Lung Protective Effects of Low-Volume Resuscitation and Pharmacologic Treatment of Swine Subjected to Polytrauma and Hemorrhagic Shock.

Authors:  Vahagn C Nikolian; Baihong Pan; Tomaz Mesar; Isabel S Dennahy; Patrick E Georgoff; Xiuzhen Duan; Baoling Liu; Xizi Wu; Michael J Duggan; Hasan B Alam; Yongqing Li
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

3.  Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial.

Authors:  Eileen M Bulger; Susanne May; Jeffery D Kerby; Scott Emerson; Ian G Stiell; Martin A Schreiber; Karen J Brasel; Samuel A Tisherman; Raul Coimbra; Sandro Rizoli; Joseph P Minei; J Steven Hata; George Sopko; David C Evans; David B Hoyt
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

4.  Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial.

Authors:  K L Mattox; P A Maningas; E E Moore; J R Mateer; J A Marx; C Aprahamian; J M Burch; P E Pepe
Journal:  Ann Surg       Date:  1991-05       Impact factor: 12.969

Review 5.  Hypertonic saline: a clinical review.

Authors:  R Tyagi; K Donaldson; C M Loftus; J Jallo
Journal:  Neurosurg Rev       Date:  2007-06-16       Impact factor: 3.042

6.  Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock.

Authors:  Eileen M Bulger; Joseph Cuschieri; Keir Warner; Ronald V Maier
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

Review 7.  Immunomodulatory effect of hypertonic saline in hemorrhagic shock.

Authors:  Javad Motaharinia; Farhad Etezadi; Azadeh Moghaddas; Mojtaba Mojtahedzadeh
Journal:  Daru       Date:  2015-10-05       Impact factor: 3.117

8.  Colloids versus crystalloids for fluid resuscitation in critically ill people.

Authors:  Sharon R Lewis; Michael W Pritchard; David Jw Evans; Andrew R Butler; Phil Alderson; Andrew F Smith; Ian Roberts
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.